Author

Xuewei Wang

China National Biotechnology (China)ORCID 0000-0001-9604-3045Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Xuewei Wang1 paper · The University of Texas at San Antonio Health Science Center

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2

Frequent Co-Authors

Changrui LuiD· 1 shared Chunxia HuiD· 1 shared Derek LustiD· 1 shared Fangjingwei Xu· 1 shared Fei LiuiD· 1 shared Fujun Hou· 1 shared Guohuan YangiD· 1 shared Hang ChengiD· 1 shared

Activity by Year

2023-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Changrui LuORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Nitric Oxide-Releasing Thixotropic Hydrogels as Antibacterial and Hemocompatible Catheter Locks

W.Y. Li, Loren K. Liebrecht, Surendra Poudel, Rebecca Goodhart, Sayaji More, Jade Montano, Derek Lust, Qingguo Xu, Martin J. Mangino, Xuewei Wang

This paper introduces a nitric oxide-releasing hydrogel catheter lock that prevents bacterial contamination and improves hemocompatibility.

ACS Biomaterials Science & Engineering · Dec 3, 2025Peer-reviewedBioengineering

Heterologous boost with mRNA vaccines against SARS-CoV-2 Delta/Omicron variants following an inactivated whole-virus vaccine

Changrui Lu, Yuntao Zhang, Xiaohu Liu, Fujun Hou, Rujie Cai, Zhibin Yu, Fei Liu, Guohuan Yang, Jun Ding, Jiang Xu, Xianwu Hua, Xinhua Cheng, Xinping Pan, Lianxiao Liu, Kang Lin, , Xiaoming Yang

This study evaluates mRNA vaccines ZSVG-02 and ZSVG-02-O as heterologous boosts following an inactivated whole-virus vaccine, showing superior protection against SARS-CoV-2 variants.

Antiviral Research · Mar 5, 2023Peer-reviewedMolecular Biology